Epirubicin, Cisplatin and Continuous Infusion 5-Fluorouracil (ECF) in Locally Advanced or Metastatic Gastric Cancer: A Single Institution Experience

Autor: F Pari, C. Rabbi, Marco Sorio, Andrea Mambrini, Giovanna Cavazzini, Annita Lusenti, Maurizio Cantore, Franco Smerieri, Enrico Aitini, D. Zamagni, Mauro Pagani, Francesca Adami

Publikováno v: Scopus-Elsevier

Aims and Background The role of chemotherapy in locally advanced or metastatic gastric cancer has been controversial, but chemotherapy has recently been shown to relieve tumor-related symptoms, improve quality of life and prolong survival when compar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12c67e2ff215cf512655b54ca38ea67d
https://doi.org/10.1177/030089160108700105

Confirmation and improvement of Sokal's prognostic classification of Ph+ chronic myeloid leukemia: The value of early evaluation of the course of the disease

Autor: G Torlontano, Anna Marina Liberati, E Dini, A Riccardi, B Bizzi, G Sala, G Rosti, L Prossomariti, Giuliana Alimena, L Luciano, Maurizio Martelli, S Rotondo, L Bruzzese, F Grignani, Rizzoli, Maria Cantonetti, E Miraglia, D Damiani, M Monaco, Graziella Pinotti, E Cacciola, G Broccia, Giorgina Specchia, G Spremolla, A Miliani, F Gavosto, Andrea Gallamini, A Delaurenzi, F Paolino, M Carotenuto, M Marangolo, T Diperri, S Nardelli, M Longinotti, C Derosa, F Pasini, G Castoldi, E Ascari, A Ambrosetti, A Difrancesco, S Morandi, A Capucci, F Ciccone, D Dini, P Iacopino, P Ferrini, F Dore, Antonello Pinto, Giuseppe Papa, M Maiolo, P Coser, R Debiase, G Danieli, P Leoni, R Cimino, F Decataldo, E. Dispensa, I Majolino, E Bianchini, R Montuori, C Bodenizza, B Rotoli, Alfonso Zaccaria, I Gentilini, F Leoni, G Perona, C Musolino, A Cajozzo, G Squadrito, R Battista, E Gallo, B Comotti, Luigi Resegotti, R Perricone, Tiziano Barbui, Renato Fanin, P Avanzini, Mauro Fiacchini, T Izzi, M Lombardo, F Buffa, Liso, L Deriu, P Guglielmi, L Mangoni, Enrico Montefusco, G Scapoli, Tura S, D Zamagni, Zagonel, P Foa, G Sparaventi, F Ricciuti, U Diprisco, N Testoni, M Aglietta, M Michieli, F Nobile, Piero Galieni, R Landolfi, A Nosari, Alessandro Pileri, C Bernasconi, A Abbadessa, A Montuoro, G Lucarelli, Eliana Zuffa, Domenico Russo, Franco Mandelli, E Morra, F Gobbi, Michele Baccarani, F Caronia, D Quaglino, F Papineschi, M Pizzuti

Publikováno v: Annals of Hematology. 63:307-314

A simple prognostic classification of Ph+ chronic myeloid leukemia (CML) was proposed in 1984 by an international study Group [23] and is now widely used for clinical purposes. That study was retrospective, and was based on disease features at diagno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::430665c445bfcedc5ca5940ed8de7004
https://doi.org/10.1007/bf01709652

Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer

Autor: M, Cantore, G, Fiorentini, G, Luppi, G, Rosati, R, Caudana, E, Piazza, G, Comella, C, Ceravolo, L, Miserocchi, A, Mambrini, A, Del Freo, D, Zamagni, E, Aitini, M, Marangolo

Publikováno v: Journal of experimentalclinical cancer research : CR. 22

Gemcitabine is considered the golden standard treatment for unresectable pancreatic adenocarcinoma. Intra-arte-rial drug administration had shown a deep rationale with some interesting results. In a multicenter phase III trial, we compared gemcitabin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::315ca816eff5299c541bf52a77d4f491
https://pubmed.ncbi.nlm.nih.gov/16767907

Regional combined with systemic chemotherapy in unresectable biliary tract cancers: a phase II study

Autor: M, Cantore, G, Fiorentini, A, Mambrini, C, Rabbi, D, Zamagni, N, Carlone, A, Manni, R, Caudana, T, Torri

Publikováno v: Journal of experimentalclinical cancer research : CR. 22

Unresectable biliary tract cancers have a very poor prognosis. No good systemic chemotherapeutic regimen is available. This study aimed to evaluated the activity and toxicity of a novel approach of combined loco-regional and systemic chemotherapy. Tw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::aa4b481ad0e8f3152a44e2a042bd4283
https://pubmed.ncbi.nlm.nih.gov/16767908

Combined irinotecan and oxaliplatin in patients with advanced pre-treated pancreatic cancer

Autor: D Zamagni, C. Rabbi, Andrea Mambrini, Andrea Manni, A. Del Freo, Calogero Iacono, Maurizio Cantore, G. Fiorentini, C. Oliani

Publikováno v: Oncology. 67(2)

Objectives: This study evaluated the clinical activity and toxicity of combination chemotherapy with irinotecan and oxaliplatin in patients with advanced pancreatic cancer that had progressed despite ≧1 course of a gemcitabine-containing regimen. M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::590254d6c6c88540e1a53e04ae3d5718
https://pubmed.ncbi.nlm.nih.gov/15539911